These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Transcriptional adaptation of Robbe-Saule M; Foulon M; Poncin I; Esnault L; Varet H; Legendre R; Besnard A; Grzegorzewicz AE; Jackson M; Canaan S; Marsollier L; Marion E Virulence; 2021 Dec; 12(1):1438-1451. PubMed ID: 34107844 [No Abstract] [Full Text] [Related]
7. Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer. Bolz M; Bénard A; Dreyer AM; Kerber S; Vettiger A; Oehlmann W; Singh M; Duthie MS; Pluschke G PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004431. PubMed ID: 26849213 [TBL] [Abstract][Full Text] [Related]
8. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer. Hall B; Simmonds R Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648 [TBL] [Abstract][Full Text] [Related]
9. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Silva MT; Portaels F; Pedrosa J Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228 [TBL] [Abstract][Full Text] [Related]
10. Chemistry of mycolactones, the causative toxins of Buruli ulcer. Kishi Y Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136 [TBL] [Abstract][Full Text] [Related]
11. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model. Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease. Phillips R; Sarfo FS; Guenin-Macé L; Decalf J; Wansbrough-Jones M; Albert ML; Demangel C J Infect Dis; 2009 Dec; 200(11):1675-84. PubMed ID: 19863437 [TBL] [Abstract][Full Text] [Related]
13. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer. Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295 [TBL] [Abstract][Full Text] [Related]
14. Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulcerans. Röltgen K; Pluschke G Methods Mol Biol; 2022; 2387():105-108. PubMed ID: 34643906 [TBL] [Abstract][Full Text] [Related]
16. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease. Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803 [TBL] [Abstract][Full Text] [Related]
17. Buruli ulcer: emerging from obscurity. Wansbrough-Jones M; Phillips R Lancet; 2006 Jun; 367(9525):1849-58. PubMed ID: 16753488 [TBL] [Abstract][Full Text] [Related]